These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 9182159
1. [A scientist's day-dream or future reality? Specific immunotherapy against cancer]. Kiessling R, Kärre K. Lakartidningen; 1997 Apr 23; 94(17):1595-600. PubMed ID: 9182159 [No Abstract] [Full Text] [Related]
2. Cancer immunotherapy--dream or reality? Nossal GJ. Aust J Ophthalmol; 1973 Oct 23; 1(3):95-100. PubMed ID: 4548844 [No Abstract] [Full Text] [Related]
3. [Cancer immunotherapy: immunologic bases, reality and hopes]. Dietrich PY, Farace F, Caignard A, Escudier B, Triebel F. Bull Cancer; 1993 Jul 23; 80(7):584-600. PubMed ID: 8204939 [Abstract] [Full Text] [Related]
5. [Immunotherapy for cancer--modern immunologic strategies in oncology]. Halama N, Zoernig I, Jäger D. Dtsch Med Wochenschr; 2008 Oct 23; 133(41):2105-8. PubMed ID: 18985564 [Abstract] [Full Text] [Related]
6. Effects of the tumor microenvironment on the efficacy of tumor immunotherapy. Neeson P, Paterson Y. Immunol Invest; 2006 Oct 23; 35(3-4):359-94. PubMed ID: 16916758 [Abstract] [Full Text] [Related]
8. Tumor vaccine: current trends in antigen specific immunotherapy. Baral R. Indian J Exp Biol; 2005 May 23; 43(5):389-406. PubMed ID: 15900903 [Abstract] [Full Text] [Related]
9. Cyclins against cancer: a novel family of tumor antigens? Klein-González N, Kondo E, von Bergwelt-Baildon MS. Immunotherapy; 2010 Sep 23; 2(5):595-7. PubMed ID: 20874640 [No Abstract] [Full Text] [Related]